• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYC在B细胞淋巴瘤发生中的作用。

Role of MYC in B Cell Lymphomagenesis.

作者信息

Korać Petra, Dotlić Snježana, Matulić Maja, Zajc Petranović Matea, Dominis Mara

机构信息

Department of Biology, Division of Molecular Biology, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.

Department of Pathology and Cytology, University Hospital Center Zagreb, 10000 Zagreb, Croatia.

出版信息

Genes (Basel). 2017 Apr 4;8(4):115. doi: 10.3390/genes8040115.

DOI:10.3390/genes8040115
PMID:28375188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5406862/
Abstract

B cell lymphomas mainly arise from different developmental stages of B cells in germinal centers of secondary lymphoid tissue. There are a number of signaling pathways that affect the initiation and development of B cell lymphomagenesis. The functions of several key proteins that represent branching points of signaling networks are changed because of their aberrant expression, degradation, and/or accumulation, and those events determine the fate of the affected B cells. One of the most influential transcription factors, commonly associated with unfavorable prognosis for patients with B cell lymphoma, is nuclear phosphoprotein MYC. During B cell lymphomagenesis, oncogenic MYC variant is deregulated through various mechanisms, such as gene translocation, gene amplification, and epigenetic deregulation of its expression. Owing to alterations of downstream signaling cascades, MYC-overexpressing neoplastic B cells proliferate rapidly, avoid apoptosis, and become unresponsive to most conventional treatments. This review will summarize the roles of MYC in B cell development and oncogenesis, as well as its significance for current B cell lymphoma classification. We compared communication networks within transformed B cells in different lymphomas affected by overexpressed MYC and conducted a meta-analysis concerning the association of MYC with tumor prognosis in different patient populations.

摘要

B细胞淋巴瘤主要起源于次级淋巴组织生发中心B细胞的不同发育阶段。有许多信号通路影响B细胞淋巴瘤发生的起始和发展。代表信号网络分支点的几种关键蛋白的功能因异常表达、降解和/或积累而发生改变,这些事件决定了受影响B细胞的命运。最具影响力的转录因子之一是核磷蛋白MYC,它通常与B细胞淋巴瘤患者的不良预后相关。在B细胞淋巴瘤发生过程中,致癌性MYC变体通过各种机制失调,如基因易位、基因扩增及其表达的表观遗传失调。由于下游信号级联的改变,过表达MYC的肿瘤性B细胞迅速增殖,避免凋亡,并对大多数传统治疗无反应。本综述将总结MYC在B细胞发育和肿瘤发生中的作用,以及其对当前B细胞淋巴瘤分类的意义。我们比较了受过表达MYC影响的不同淋巴瘤中转化B细胞内的通讯网络,并对不同患者群体中MYC与肿瘤预后的关联进行了荟萃分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/8efe82f7607a/genes-08-00115-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/0d236f4654d2/genes-08-00115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/3f5298d80eef/genes-08-00115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/8efe82f7607a/genes-08-00115-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/0d236f4654d2/genes-08-00115-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/3f5298d80eef/genes-08-00115-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9348/5406862/8efe82f7607a/genes-08-00115-g003.jpg

相似文献

1
Role of MYC in B Cell Lymphomagenesis.MYC在B细胞淋巴瘤发生中的作用。
Genes (Basel). 2017 Apr 4;8(4):115. doi: 10.3390/genes8040115.
2
[Molecular abnormalities in lymphomas].[淋巴瘤中的分子异常]
Bull Cancer. 2010 Nov;97(11):1347-64. doi: 10.1684/bdc.2010.1214.
3
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects.c-MYC在B细胞淋巴瘤中的作用:诊断与分子层面
Genes (Basel). 2017 Apr 5;8(4):116. doi: 10.3390/genes8040116.
4
Advances in the understanding of MYC-induced lymphomagenesis.对 MYC 诱导的淋巴瘤发生机制的认识进展。
Br J Haematol. 2010 May;149(4):484-97. doi: 10.1111/j.1365-2141.2010.08159.x. Epub 2010 Mar 21.
5
Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors.惰性B细胞淋巴瘤的转基因N-myc小鼠模型:自发肿瘤和逆转录病毒加速肿瘤的肿瘤特征及基因改变分析
Oncogene. 1998 Oct 22;17(16):2073-85. doi: 10.1038/sj.onc.1202125.
6
A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.p53 缺陷使携带 IgH 3' 调控区驱动 c-myc 转基因的小鼠中各种 B 细胞发育阶段易发生淋巴瘤形成。
J Immunol. 2011 Dec 1;187(11):5772-82. doi: 10.4049/jimmunol.1102059. Epub 2011 Oct 28.
7
MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.MYC在淋巴肿瘤中的失调:分子机制、临床后果及治疗意义。
Biochim Biophys Acta. 2014 Dec;1846(2):457-67. doi: 10.1016/j.bbcan.2014.08.006. Epub 2014 Sep 6.
8
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.除MYC易位外的伯基特淋巴瘤:N-MYC与DNA甲基转移酶失调
BMC Cancer. 2015 Oct 9;15:668. doi: 10.1186/s12885-015-1661-7.
9
Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.滤泡性淋巴瘤和转化型淋巴瘤中bcl-2和c-myc转录调控的分子机制
Cancer Res. 2001 Jul 1;61(13):5202-6.
10
Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.在临床上侵袭性的IGH/BCL2阳性生发中心B细胞淋巴瘤中IGH/MYC融合基因的扩增
Genes Chromosomes Cancer. 2005 Aug;43(4):414-23. doi: 10.1002/gcc.20187.

引用本文的文献

1
Dexamethasone Inhibits the Growth of B-Lymphoma Cells by Downregulating DOT1L.地塞米松通过下调 DOT1L 抑制 B 淋巴瘤细胞的生长。
Cancer Rep (Hoboken). 2024 Sep;7(9):e2150. doi: 10.1002/cnr2.2150.
2
Metabolic Biomarkers in B-Cell Lymphomas for Early Diagnosis and Prediction, as Well as Their Influence on Prognosis and Treatment.B细胞淋巴瘤中用于早期诊断和预测的代谢生物标志物及其对预后和治疗的影响
Diagnostics (Basel). 2022 Feb 3;12(2):394. doi: 10.3390/diagnostics12020394.
3
Non-Hodgkin Lymphoma Metabolism.非霍奇金淋巴瘤代谢。

本文引用的文献

1
C-MYC Involvement in Chronic Lymphocytic Leukemia (CLL): A Molecular and Cytogenetic Update.C-MYC与慢性淋巴细胞白血病(CLL):分子与细胞遗传学最新进展
J Assoc Genet Technol. 2015;41(4):176-183.
2
MYC rearranged B-cell neoplasms: Impact of genetics on classification.MYC重排的B细胞肿瘤:遗传学对分类的影响。
Cancer Genet. 2016 Oct;209(10):431-439. doi: 10.1016/j.cancergen.2016.08.007. Epub 2016 Sep 14.
3
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.
Adv Exp Med Biol. 2021;1311:103-116. doi: 10.1007/978-3-030-65768-0_7.
4
Gene Transactivation and Transrepression in MYC-Driven Cancers.MYC 驱动型癌症中的基因激活和转录抑制。
Int J Mol Sci. 2021 Mar 27;22(7):3458. doi: 10.3390/ijms22073458.
5
Impact of MYC on Anti-Tumor Immune Responses in Aggressive B Cell Non-Hodgkin Lymphomas: Consequences for Cancer Immunotherapy.MYC对侵袭性B细胞非霍奇金淋巴瘤抗肿瘤免疫反应的影响:对癌症免疫治疗的影响
Cancers (Basel). 2020 Oct 20;12(10):3052. doi: 10.3390/cancers12103052.
6
Cross-talk between Myc and p53 in B-cell lymphomas.B细胞淋巴瘤中Myc与p53之间的相互作用。
Chronic Dis Transl Med. 2019 Oct 22;5(3):139-154. doi: 10.1016/j.cdtm.2019.08.001. eCollection 2019 Sep.
7
Germinal Centre B Cell Functions and Lymphomagenesis: Circuits Involving MYC and MicroRNAs.生发中心 B 细胞的功能与淋巴瘤发生:涉及 MYC 和 microRNAs 的通路。
Cells. 2019 Oct 31;8(11):1365. doi: 10.3390/cells8111365.
8
Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients.膀胱癌患者个体化自噬临床预后指数的识别与验证
Onco Targets Ther. 2019 May 14;12:3695-3712. doi: 10.2147/OTT.S197676. eCollection 2019.
9
E3 ubiquitin ligases in B-cell malignancies.E3 泛素连接酶在 B 细胞恶性肿瘤中的作用。
Cell Immunol. 2019 Jun;340:103905. doi: 10.1016/j.cellimm.2019.02.004. Epub 2019 Feb 26.
10
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.非霍奇金B细胞淋巴瘤中与MYC相关的微小RNA特征及其与核心细胞通路的关系。
Oncotarget. 2018 Jul 3;9(51):29753-29771. doi: 10.18632/oncotarget.25707.
P53表达与弥漫性大B细胞淋巴瘤较差的生存率相关,并增强了MYC重排、表达或同时存在的MYC/BCL2表达的负面预后影响。
Mod Pathol. 2017 Feb;30(2):194-203. doi: 10.1038/modpathol.2016.178. Epub 2016 Oct 14.
4
BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects.BET抑制剂在血液系统恶性肿瘤治疗中的应用:当前见解与未来展望
Onco Targets Ther. 2016 Sep 28;9:5943-5953. doi: 10.2147/OTT.S100515. eCollection 2016.
5
Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression.MYC蛋白表达在中枢神经系统弥漫性大B细胞淋巴瘤中的预后影响:与MYC重排及MYC mRNA表达的比较
Mod Pathol. 2017 Jan;30(1):4-14. doi: 10.1038/modpathol.2016.56. Epub 2016 Sep 30.
6
PELI1 expression is correlated with MYC and BCL6 expression and associated with poor prognosis in diffuse large B-cell lymphoma.PELI1 的表达与 MYC 和 BCL6 的表达相关,与弥漫性大 B 细胞淋巴瘤的不良预后相关。
Mod Pathol. 2016 Nov;29(11):1313-1323. doi: 10.1038/modpathol.2016.128. Epub 2016 Jul 29.
7
MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.MYC和BCL2过表达与纪念斯隆凯特琳癌症中心预后模型的更高分级以及原发性中枢神经系统弥漫性大B细胞淋巴瘤的不良临床结局相关。
BMC Cancer. 2016 Jun 10;16:363. doi: 10.1186/s12885-016-2397-8.
8
MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma.MYC易位和/或BCL 2蛋白表达与弥漫性大B细胞淋巴瘤的不良预后相关。
Cancer Sci. 2016 Jun;107(6):853-61. doi: 10.1111/cas.12942. Epub 2016 May 6.
9
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
10
Repurposing the CRISPR-Cas9 system for targeted DNA methylation.将CRISPR-Cas9系统用于靶向DNA甲基化的重新利用。
Nucleic Acids Res. 2016 Jul 8;44(12):5615-28. doi: 10.1093/nar/gkw159. Epub 2016 Mar 11.